SCHEMBL5519045

SCHEMBL5519045

COC(=O)[C@H](CC(C)(C)C)C(C)C

nearest known ligand 0.41

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.41
CA14 Q9ULX7 4/20 0.36
CA12 O43570 3/20 0.36
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
MMP8 P22894 1/20 0.34
CA7 P43166 2/20 0.33
CA9 Q16790 1/20 0.33
PIK3CD O00329 1/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12135638 1.00 SMN1; SMN2 (0.41) SMN1; SMN2CA14CA12CA1CA2
SCHEMBL15340774 0.85 SMN1; SMN2 (0.35) SMN1; SMN2CA14CA12CA1CA2
SCHEMBL22661736 0.81 MMP8 (0.30) MMP8
SCHEMBL14220668 0.81 CA1 (0.38) CA14CA12CA1CA2MMP8
SCHEMBL18469147 0.80 MMP8 (0.31) MMP8
SCHEMBL19222797 0.79 TSHR (0.39) SMN1; SMN2MMP8TSHR
SCHEMBL14542454 0.79
SCHEMBL13174627 0.78 ALDH1A1 (0.33) TSHR
SCHEMBL22810807 0.78 GRM1 (0.35) MMP8TSHR
SCHEMBL5539779 0.77 SMN1; SMN2 (0.39) SMN1; SMN2CA14CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8367666-B2 3-carbamoyl-2-pyridone derivatives SHIONOGI & CO., LTD. (JP) 2013-02-05 US disclosed
US-8367666-B2 3-carbamoyl-2-pyridone derivatives SHIONOGI & CO., LTD. (JP) 2013-02-05 US disclosed
US-8178681-B2 methyl 3-methyl-2-{[2-oxo-1-(2-oxo-ethyl)-1,2,5,6,7,8,9,10-octahydro-cycloocta[b]pyridine-3-carbonyl]-amino}-butyrate; cannabinoid receptor agonist; antiinflammatory agent, immunostimulant, analgesic; atopic dermatitis; excellent in photostability, and have excellent transdermal and oral absorbency SHIONOGI & CO., LTD. (JP) 2012-05-15 US disclosed